XML 70 R51.htm IDEA: XBRL DOCUMENT v3.20.4
RediTrex® and Vibativ® - Vibativ Acquisition - Schedule of Contingent Consideration and Preliminary Allocation (Details) - USD ($)
 1 Months Ended 2 Months Ended 12 Months Ended
Mar. 08, 2019
Nov. 30, 2018
Dec. 31, 2018
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Business Acquisition [Line Items]            
Cash paid at closing       $ 0 $ 5,000,000 $ 20,000,000
Goodwill       882,000 882,000  
VIBATIV            
Business Acquisition [Line Items]            
Cash paid at closing   $ 20,000,000.0   20,000,000    
Cash payment during early 2019 $ 5,000,000.0     5,000,000    
Fair value of contingent consideration - net sales royalty       9,182,000    
Total consideration       34,182,000    
Balance at November 12, 2018       8,633,589 9,502,000  
Change in fair value of contingent consideration included in operating expenses     $ (40,000) (1,160,202) (804,167)  
Contingent consideration earned and accrued in operating expenses     508,000 1,546,346 820,864  
Adjustment to initial fair value of the contingent consideration liability         148,000  
Cash payment of royalty during the period       819,180 1,033,108  
Balance at December 31, 2018     $ 9,502,000 $ 8,200,553 $ 8,633,589 $ 9,502,000
Finished goods inventory   6,624,000        
Work in process - unlabeled vials   3,970,000        
Work in process - validation vials   1,827,000        
Raw materials   9,129,000        
Total inventory   21,550,000        
Intellectual property amortizable intangible assets   11,750,000        
Goodwill   882,000        
Total intangibles and goodwill   12,632,000        
Total assets acquired   $ 34,182,000